Der Human Monoklonal anti-SARS-CoV-2 Nucleocapsid Antikörper wird verwendet zum Nachweis von SARS-CoV-2 Nucleocapsid in Proben von SARS Coronavirus-2 (SARS-CoV-2) und SARS Coronavirus (SARS-CoV). Er wurde validiert für ELISA, WB, FACS und IFA.
Human anti-SARS-CoV & CoV-2 NP antibody recognize human SARS Coronavirus Nucleocapsid protein (NP). Coronavirus NP localize to the cytoplasm and the nucleolus in both Virus-like particle (VLP) infected primary cells and in cells transfected with NP plasmid. NP has abundant expression in coronavirus and is a highly immunogenic phosphoprotein. NP is also conserved in sequence. Due to these characteristic above, the NP is an ideal marker for diagnosis.